Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Amplia Therapeutics falls as HY loss widens

** Shares of Amplia Therapeutics ATX.AX fall 3.6% to A$0.135, on track for their weakest session since November 18
** The clinical-stage, drug development co's HY loss attributable widens to A$4.2 million ($2.75 million) from A$2.8 million last year
** However, ATX up 21.7% this week, set for its strongest week since July 10
** Stock up 51.7% YTD

($1 = 1.5300 Australian dollars)

 (Reporting by Jasmeen Ara Shaikh in Bengaluru)

 ((Jasmeenaraislam.shaikh@thomsonreuters.com ))

Recent news on Amplia Therapeutics

See all news